Navigation Links
Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
Date:11/4/2013

(PRWEB) November 04, 2013

The report "Global Biosimulation Market (Insilico Technology Markets for Drug Development) (2012 - 2017)" defines and segments the global biosimulation market with analysis of forecasting of the global revenue and applications revenue for biosimulation. It also identifies driving and restraining factors for the global biosimulation market with analysis of trends, opportunities, challenges, strengths, weakness and threats. The market is segmented and revenue is forecasted on the basis of major region such as North America, Europe, Asia and Rest of the World. Market is segmented and revenues are forecasted on the basis of application and region.

Browse more than 51 market data tables/figures spread through 130 pages and in-depth TOC on "Biosimulation Market".

http://www.marketsandmarkets.com/Market-Reports/biosimulation-market-838.html

Early buyers will receive 10% customization on this report.

Biosimulation is one the fastest growing technology applied in drug discovery and development process. The decline in output and increase in cost in R&D for new drug discovery and development is a major growth factor for the biosimulation. With many drug candidates failing in the late development stages, pharmaceutical companies are under pressure to reduce cost spent by focusing only on specific experiments, Biosimulation aids in focusing on potentially safe drug candidate and developing it into a successful drug.

The key growth area is application of Pharmacokinetic/pharmacodynamic (PKPD) modeling in pre clinical development it is the most widely used model in drug development process which is driving the growth of biosimulation.

Modelling and simulation are widely used across the drug development process in large and small pharmaceutical companies. Pharmaceutical companies realize that integrating existing knowledge and using quantitative simulation methods offer significant savings in time, money and material over expensive in vitro and in vivo studies. The global market for biosimulation in terms of revenue was estimated to be worth $432.0 million in 2011 and is expected to reach $1.2 billion by 2017, growing at a CAGR of 18.50% from 2012 to 2017.

Browse Related Reports

Pharmaceutical Excipients Market [By Products (Carbohydrates, Oleochemicals, Petrochemicals, Polymers, Microcrystalline Cellulose, Sugar, Calcium carbonate), By Functionality (Fillers, Binders, Lubricants, Preservatives)] – Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

North America Weight Loss /Obesity Management Market – [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] – Forecasts to 2017

http://www.marketsandmarkets.com/Market-Reports/north-america-weight-loss-obesity-management-market-1213.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarket

Read the full story at http://www.prweb.com/releases/biosimulation-market/11/prweb11298031.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biosimulation Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
2. Biosimulation Market (Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
3. Majority of states fail to address youth exposure to alcohol marketing
4. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
5. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
6. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
7. Dotcomsecrets is Offering New Opportunities to People Who Want to Become Expert in Localized Internet Marketing
8. 101 Mobility Opens Franchise in Roanoke/Lynchburg Market
9. How MyTownInsurance.com Helps Insurance Carriers Manage their Loss Exposure through On-Line Marketing
10. Discount Supermarkets Tied to Rising Obesity Rates
11. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... , ... Mercy College is expanding its Graduate Business Programs to the Bronx ... to high demand: Master of Business Administration (MBA), Master of Organizational Leadership (MSOL) and ... School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe that people ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Council for Graduate Medical Education (ACGME) that it has received accreditation for its ... accreditation of three residency programs that Memorial is currently pursuing, including Pediatrics and ...
(Date:4/29/2016)... Atlanta, Georgia (PRWEB) , ... April 29, 2016 , ... ... 60 rural hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on ... by Rep. Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced efforts ... more information about their loan terms and accounts, and more protections for borrowers. ... federal and private loans, has reached $1.3 trillion, with 43 million Americans holding ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... infants born with severe congenital diaphragmatic hernia have better survival rates if surgery ... diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
Breaking Medicine Technology: